KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Equity (2016 - 2025)

Historic Return on Equity for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.07%.

  • Biogen's Return on Equity fell 300.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.07%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.07% for FY2025, which is 300.0% down from last year.
  • As of Q4 2025, Biogen's Return on Equity stood at 0.07%, which was down 300.0% from 0.09% recorded in Q3 2025.
  • Over the past 5 years, Biogen's Return on Equity peaked at 0.29% during Q1 2021, and registered a low of 0.07% during Q4 2025.
  • For the 5-year period, Biogen's Return on Equity averaged around 0.14%, with its median value being 0.12% (2023).
  • As far as peak fluctuations go, Biogen's Return on Equity crashed by -2800bps in 2021, and later skyrocketed by 1000bps in 2023.
  • Over the past 5 years, Biogen's Return on Equity (Quarter) stood at 0.16% in 2021, then skyrocketed by 46bps to 0.23% in 2022, then crashed by -65bps to 0.08% in 2023, then increased by 24bps to 0.1% in 2024, then fell by -28bps to 0.07% in 2025.
  • Its Return on Equity was 0.07% in Q4 2025, compared to 0.09% in Q3 2025 and 0.09% in Q2 2025.